GoHealth Reports Third Quarter 2020 Results and Increases 2020 Outlook As a Result of Strong Medicare Enrollments and Operating Leverage CHICAGO

GoHealth Reports Third Quarter 2020 Results and Increases 2020 Outlook

As a Result of Strong Medicare Enrollments and Operating Leverage

CHICAGO, November 11, 2020 GoHealth, Inc. (GoHealth or the Company) (Nasdaq: GOCO), a leading health insurance marketplace, announced financial

results for the three and nine months ended September 30, 2020.

co-founder and CEO said, GoHealth s third quarter adjusted EBITDA growth of 142% was powered by 52% revenue growth and strong operating leverage as we continue to efficiently scale the business.

These excellent results marked a continuation of year-to-date trends as consumers increasingly turn to GoHealth s leading DTC platform to find the best Medicare

policies to meet their unique needs.

Jones continued, Our proprietary, vertically-integrated technology platform and high performance

marketing organization allow us to efficiently grow our carrier partners Medicare membership base. This growth is guided by our LTV/CAC focus, ensuring that we generate quick payback periods. Our TeleCare team administers GoHealth s

Encompass programs on behalf of our carrier partners and further supports consumer persistency by proactively engaging with and educating consumers about their benefits through Plan Fit Check calls. The strength and differentiation of our business

model is evident in our third quarter operating cash flow of $33 million as well as a 5% increase in LTVs, fueled by improving persistency trends.

Year-To-Date 2020 Highlights

The trajectory of the US economy remains challenging to predict, particularly given the heightened uncertainty associated with the COVID-19 pandemic. During this time, demand for healthcare has demonstrated great resilience, and we believe that the COVID-19 pandemic has created favorable industry dynamics

for technology-driven direct-to-consumer models such as GoHealth s insurance marketplace. The Company has updated its outlook for the fiscal year ending

December 31, 2020 based on current market conditions and expectations:

Jones concluded, We are increasing our expectations for fiscal 2020 given our robust

start to the Annual Enrollment Period, with October submissions up 83% over the prior October and well ahead of the 53% implied midpoint of revenue growth for the fourth quarter. The Medicare market is large and growing quickly, and we are just

beginning to realize our long-term growth opportunity as we create value for our partners and deliver great results for our shareholders.

Conference Call Details

The Company will host a

conference call today, Wednesday, November 11, 2020 at 5:00 pm (ET) to discuss its financial results. A live audio webcast and a supplemental presentation will be available online at https://investors.gohealth.com. The conference call

can also be accessed by dialing 1-833-519-1310 for U.S. participants, or 1-914-800-3876 for international participants, and referencing participant code 4374976. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link.

As a leading health insurance marketplace, GoHealth s mission is to improve access to healthcare in America. Enrolling in a health insurance plan can be

confusing for customers, and the seemingly small differences between plans can lead to significant out-of-pocket costs or lack of access to critical medicines and even

providers. GoHealth combines cutting-edge technology, data science and deep industry expertise to match customers with the healthcare policy and carrier that is best for them. Since its inception, GoHealth has enrolled millions of people in Medicare

and individual and family plans. For more information, visit https://www.gohealth.com

Jay Koval, VP of Investor Relations

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than

statements of historical facts contained in this press release may be forward-looking statements. Statements regarding the Company s future results of operations and financial position, business strategy and plans and objectives of management

for future operations, including, among others, statements regarding expected financial performance and operational performance for the fiscal year 2020, including with respect to revenue and Adjusted EBITDA, and the Company s performance

during the Annual Enrollment Period, including with respect to agent conversion and implied growth for the fourth quarter of 2020, are forward-looking statements. In some cases, you can identify forward-looking statements by terms, such as

may, will, should, expects, plans, anticipates, could, intends, targets, projects, contemplates,

believes, estimates, predicts, potential or continue or the negative of these terms or other similar expressions. Accordingly, we caution you that any such forward-looking statements are

not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the

date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause the Company s actual results to differ materially

from those indicated in these forward-looking statements, including, but are not limited to, the following: the Company s ability to comply with the numerous, complex and frequently changing laws regulating the marketing and sale of Medicare

plans; the potential for an adverse change in the Company s relationships with carriers, including a loss of a carrier relationships; failure to grow the Company s customer base or retain its existing customers; carriers ability to

reduce commissions paid to the Company and adversely change their underwriting practices; significant consolidation in the healthcare industry which could adversely alter the Company s relationships with carriers; information technology systems

failures or capacity constraints interrupting the Company s operations; factors that adversely impact the Company s estimate of LTV; the Company s dependence on agents to sell insurance plans; changes in the health insurance system

and laws and regulation governing health insurance markets; the inability to effectively advertise the Company s products; and our ability to successfully implement our business plan during a global economic downturn caused by the COVID-19 pandemic.

The foregoing factors should not be construed as exhaustive and should be read together with the

other cautionary statements included in this press release, as well as the cautionary statements and other risk factors set forth in the Company s Quarterly Report on Form 10-Q for the third quarter ended

September 30, 2020 filed with the SEC. If one or more events related to these or other risks or uncertainties materialize, or if the Company s underlying assumptions prove to be incorrect, actual results may differ materially from what the

Company anticipates. Many of the important factors that will determine these results are beyond the Company s ability to control or predict. Accordingly, you should not place undue reliance on any such forward-looking statements. Any

forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, the Company does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new

information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, the Company cannot assess the impact of each factor on its business or the extent to which

any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Use of Non-GAAP Financial Measures and Key Performance Indicators

In this press release, we use supplemental measures of

our performance that are derived from our consolidated financial information, but which are not presented in our Consolidated Financial Statements prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures include net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization expense, or EBITDA; Adjusted EBITDA and Adjusted EBITDA margin. Adjusted

EBITDA is the primary financial performance measure used by management to evaluate its business and monitor its results of operations.

represents EBITDA as further adjusted for share-based compensation, expense related to the accelerated vesting of certain equity awards, change in fair value of contingent consideration liability, Centerbridge Acquisition costs, severance costs and

incremental organizational costs in connection with the IPO. Adjusted EBITDA margin represents Adjusted EBITDA divided by net revenues.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated

financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe

these non-GAAP financial measures provide our stakeholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and

enabling them to make more meaningful period to period comparisons. There are limitations to the use of the non-GAAP financial measures presented in this press release. For example, our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP

financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

The non-GAAP financial measures are not meant to be considered as

indicators of performance in isolation from or as a substitute for net income (loss) prepared in accordance with GAAP, and should be read only in conjunction with financial information presented on a GAAP basis. Reconciliations of each of EBITDA and

Adjusted EBITDA to its most directly comparable GAAP financial measure, net income (loss), are presented in the tables below in this press release. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future periods, we may exclude similar items, may incur income and expenses similar to these excluded items and include other expenses, costs and non-recurring items.

Management has provided its outlook regarding adjusted EBITDA, which is a non-GAAP financial measure and excludes certain charges. Management has not reconciled these non-GAAP financial measures to the corresponding GAAP financial measures because

guidance for the various reconciling items are not provided. Management is unable to provide guidance for these reconciling items because we cannot determine their probable significance, as certain items are outside of our control and cannot be

reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.

LTV/CAC refers to the Lifetime Value of Commissions per Consumer Acquisition Cost, which we define as (i) aggregate commissions estimated to

be collected over the estimated life of all commissionable Approved Submissions for the relevant period based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied

constraints, or LTV, divided by (ii) the cost to convert a prospect into a customer less other noncommission carrier revenue for such period, or CAC. CAC is comprised of cost of revenue, marketing and advertising expenses and customer care and

enrollment expenses less other revenue and is presented on a per commissionable Approved Submission basis. Approved Submissions refer to Submitted Policies approved by carriers for the identified product during the indicated period.

LTV Per Approved Submission refers to the Lifetime Value of Commissions per Approved Submission, which we define as (i) aggregate commissions estimated to be collected over the estimated life of all commissionable Approved

Submissions for the relevant period based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints, divided by (ii) the number of commissionable

Approved Submissions for such period.

On September 13, 2019, Centerbridge Capital Partners III, L.P., indirectly through a subsidiary of GoHealth Holdings, LLC, (formerly known as Blizzard

Parent, LLC), an entity formed in contemplation of the acquisition, acquired a 100% interest in Norvax, LLC. We refer to this transaction as the Centerbridge Acquisition. As a result of the Centerbridge Acquisition, the Company s

financial results for the three and nine months ended September 30, 2019 are presented for two periods, the Predecessor and Successor periods, which relate to the period preceding the acquisition on September 13, 2019 and the period

succeeding the acquisition, respectively. The Company s financial results for the periods from July 1, 2019 through September 12, 2019 and from January 1, 2019 through September 12, 2019 are referred to as those of the

Predecessor period. The Company s financial results for the period from September 13, 2019 through September 30, 2019, the three months ended September 30, 2020 and the nine months ended September 30, 2020 are

referred to as those of the Successor period. The Company s results of operations as reported in our Consolidated Financial Statements for these periods are prepared in accordance with GAAP. Although GAAP requires that we report on

the Company s results for the period from July 1, 2019 through September 12, 2019, from January 1, 2019 through September 12, 2019 and the period from September 13, 2019 through September 30, 2019 separately,

management views the Company s operating results for the three and nine months ended September 30, 2019 by combining the results of the applicable Predecessor and Successor periods because such presentation provides the most meaningful

comparison to its results for the three and nine months ended September 30, 2020.

The Company cannot adequately benchmark the operating results of

the period from September 13, 2019 through September 30, 2019 against any of the current periods reported in its Consolidated Financial Statements without combining it with the period from July 1, 2019 through September 12, 2019

and the period from January 1, 2019 through September 12, 2019 and does not believe that reviewing the results of this period in isolation would be useful in identifying trends in or reaching conclusions regarding the Company s

overall operating performance. Management believes that the key performance metrics such as revenue, net (loss) income and Adjusted EBITDA for the Successor period when combined with the Predecessor period provides more meaningful comparisons to

other periods and are useful in identifying current business trends. Accordingly, in addition to presenting the Company s results of operations as reported in our Consolidated Financial Statements in accordance with GAAP, the tables and

discussion throughout this press release also present the combined results for the three and nine months ended September 30, 2019.

results for the three months ended September 30, 2019, which we refer to herein as the results for the three months ended September 30, 2019 represent the sum of the reported amounts for the Predecessor period from July 1,

2019 through September 12, 2019 and the Successor period from September 13, 2019 through September 30, 2019. The combined results for the nine months ended September 30, 2019, which we refer to herein as the results for the

nine months ended September 30, 2019 represent the sum of the reported amounts for the Predecessor period from January 1, 2019 through September 12, 2019 and the Successor period from September 13, 2019 through

September 30, 2019. The combined results do not reflect the actual results the Company would have achieved had the Centerbridge Acquisition occurred on January 1, 2019 and may not be indicative of future results. These combined results are

not considered to be prepared in accordance with GAAP and have not been prepared on a pro forma basis, which would reflect pro forma adjustments including, but not limited to: amortization expense for intangible assets, share-based compensation

expense related to the Centerbridge Acquisition and the IPO, and transaction-related costs related to the Centerbridge Acquisition and the IPO.

The following table sets forth the components of our results of operations for the periods indicated

The following table sets forth the reconciliations of GAAP net loss to EBITDA and Adjusted EBITDA for the

The following table summarizes share based compensation by operating function: